Search
Now showing items 1-3 of 3
Cutaneous Side Effects of Single Versus Combined BRAF Inhibitors: A Comment to Erfan et al. Reply
(Acta Dermato-Venereologica, 2017)
[No Abstract Available]
Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors
(Acta Dermato-Venereologica, 2017)
[No Abstract Available]
Reply to the comments by Anforth and Fernandez-Penas
(Medical Journals/Acta D-V, 2017)
[No abstract available]